Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension

Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension

Andrew L Dodgen,1 Kevin D Hill1,2 1Department of Pediatrics, Duke University Medical Center, 2Duke Clinical Research Institute, Durham, NC, USA Abstract: Sildenafil is a phosphodiesterase type-5 inhibitor approved for treatment of pulmonary arterial hypertension (PAH) in adults. Data from pediatric...

Full description

Bibliographic Details
Main Authors: Dodgen AL, Hill KD
Format: Article
Language:English
Published: Dove Medical Press 2015-12-01
Series:Drug, Healthcare and Patient Safety
Subjects:
Sildenafil
Safety
Pediatric Pulmonary Arterial Hypertension
Online Access:https://www.dovepress.com/safety-and-tolerability-considerations-in-the-use-of-sildenafil-for-ch-peer-reviewed-article-DHPS

Internet

https://www.dovepress.com/safety-and-tolerability-considerations-in-the-use-of-sildenafil-for-ch-peer-reviewed-article-DHPS

Similar Items